title: Primary B cell lymphoma of the tongue base: a case report.
abstract: Primary non-Hodgkin's lymphoma's of the tongue is very rare and accounts for 1% of all malignant tumor of the oral cavity. Clinical features are non-specific ulcerative lesions that do not heal. In the literature, the majority of cases are diffuse large B cell type however, T cell phenotype also may occur. We describe a 77 years old man, who presented with an ulcerative mass in the left margin of the tongue the diagnosis diffuse large B cell lymphoma was confirmed. The patient is actually on treatment R-mini CEOP and has favorable evolution.
authors.affiliation: Department of Hematology Farhat Hached Hospital, Sousse, Tunisia.
authors.forename: Achour
authors.initials: A
authors.lastname: Bechir
authors.affiliation: Department of Imaging Farhat Hached Hospital, Sousse, Tunisia.
authors.forename: Achour
authors.initials: A
authors.lastname: Asma
authors.affiliation: Department of Hematology Farhat Hached Hospital, Sousse, Tunisia.
authors.forename: Regaieg
authors.initials: R
authors.lastname: Haifa
authors.affiliation: Department of Pathology Farhat Hached Hospital, Sousse, Tunisia.
authors.forename: Abdessayed
authors.initials: A
authors.lastname: Nesrine
authors.affiliation: Department of Hematology Farhat Hached Hospital, Sousse, Tunisia.
authors.forename: Ben Youssef
authors.initials: BY
authors.lastname: Yosra
authors.affiliation: Department of Pathology Farhat Hached Hospital, Sousse, Tunisia.
authors.forename: Sriha
authors.initials: S
authors.lastname: Badreddine
authors.affiliation: Department of Hematology Farhat Hached Hospital, Sousse, Tunisia.
authors.forename: Khelif
authors.initials: K
authors.lastname: Abderrahim
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D015251:Epirubicin / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab / Q000008:administration & dosage; D014062:Tongue Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D015251:Epirubicin; D000069283:Rituximab; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
keywords: B-cell neoplasms; Non Hodgkin lymphoma; tongue